Oncologic outcomes for ablative therapy of kidney cancer

Sangtae Park, Jeffrey A Cadeddu, W. Bruce Shingleton

Research output: Contribution to journalReview articlepeer-review

10 Scopus citations


Needle ablative therapies for small incidental renal masses are emerging as alternatives to traditional extirpative surgery. Reasons include their associated decreased morbidity, shorter convalescence, and the ability to avert the higher risk of extirpative surgery in an aging patient population. Cryoablation (CA) and radiofrequency ablation are the two most thoroughly studied needle ablative methods used for renal cancer. High-intensity focused ultrasound has also been studied but with limited published human experience at this time. For both radiofrequency ablation and CA, in vitro experiments, animal studies, and (increasingly) human experience have been published, allowing us to define appropriate candidates for such therapies, their oncologic outcomes, and the potential pitfalls. While long-term data is being collected, the current literature suggests that CA and radiofrequency ablation can be safely performed and can effectively eradicate small renal cancers with cancer-specific survival rates similar to those of traditional surgical options.

Original languageEnglish (US)
Pages (from-to)31-37
Number of pages7
JournalCurrent urology reports
Issue number1
StatePublished - Jan 2007

ASJC Scopus subject areas

  • Urology


Dive into the research topics of 'Oncologic outcomes for ablative therapy of kidney cancer'. Together they form a unique fingerprint.

Cite this